Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.

Latest updates to the Pembrolizumab in HCC Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor internal update to the page's version/metadata without altering the study content.SummaryDifference0.1%

- Check12 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a newer version of the site’s code or template. The change appears to be a backend patch rather than a modification to study content or user-facing data.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page now indicates that enrollment is closed, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision update to v3.6.0 and formatting adjustments to the Intervention/Treatment label.SummaryDifference0.5%

- Check34 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded the revision label 'Revision: v3.5.4' and removed 'Revision: v3.5.3'. This reflects an update to the page's revision history rather than any substantive change to trial data or content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page footer version has been updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a platform/version change rather than an update to the study record itself.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.